Elix
Elix, Inc. is an AI drug discovery company based in Tokyo, Japan, that offers a comprehensive platform combining predictive and generative AI models with expert consulting to innovate drug discovery beyond traditional medicinal chemistry. Their platform, Elix Discovery™, supports proposing novel molecular structures beyond human imagination, backed by multiple success stories. The company emphasizes openness and knowledge sharing to foster collaborative research and provides extensive consulting to ensure effective adoption of AI tools by chemists. Elix collaborates with pharmaceutical companies, academic institutions, and startups, serving clients such as Astellas Pharma, Shionogi, and Mitsubishi Chemical. Founded in 2016, Elix integrates advanced AI technologies and deep domain expertise to accelerate drug discovery and maximize successful outcomes in the pharmaceutical industry.
Elix
Elix, Inc. is an AI drug discovery company based in Tokyo, Japan, that offers a comprehensive platform combining predictive and generative AI models with expert consulting to innovate drug discovery beyond traditional medicinal chemistry. Their platform, Elix Discovery™, supports proposing novel molecular structures beyond human imagination, backed by multiple success stories. The company emphasizes openness and knowledge sharing to foster collaborative research and provides extensive consulting to ensure effective adoption of AI tools by chemists. Elix collaborates with pharmaceutical companies, academic institutions, and startups, serving clients such as Astellas Pharma, Shionogi, and Mitsubishi Chemical. Founded in 2016, Elix integrates advanced AI technologies and deep domain expertise to accelerate drug discovery and maximize successful outcomes in the pharmaceutical industry.